Gregory A. Korbel

2022

In 2022, Gregory A. Korbel earned a total compensation of $601.3K as Former Chief Operating Officer at Aprea Therapeutics, a 10% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$107,292
Option Awards$128,010
Salary$310,417
Stock Awards$55,607
Total$601,326

Korbel received $310.4K in salary, accounting for 52% of the total pay in 2022.

Korbel also received $107.3K in non-equity incentive plan, $128K in option awards and $55.6K in stock awards.

Rankings

In 2022, Gregory A. Korbel's compensation ranked 4,062nd out of 5,756 executives tracked by ExecPay. In other words, Korbel earned more than 29.4% of executives.

ClassificationRankingPercentile
All
4,062
out of 5,756
29th
Division
Manufacturing
2,294
out of 3,133
27th
Major group
Chemicals And Allied Products
1,112
out of 1,419
22nd
Industry group
Drugs
1,043
out of 1,320
21st
Industry
Pharmaceutical Preparations
764
out of 966
21st
Source: SEC filing on July 11, 2023.

Korbel's colleagues

We found four more compensation records of executives who worked with Gregory A. Korbel at Aprea Therapeutics in 2022.

2022

Christian Schade

Aprea Therapeutics

Chief Executive Officer

2022

Scott Coiante

Aprea Therapeutics

Chief Financial Officer

2022

Eyal Attar

Aprea Therapeutics

Chief Medical Officer

2022

Oren Gilad

Aprea Therapeutics

Chief Executive Officer

News

You may also like